Stevens First Principles Investment Advisors’s GSK GSK Stock Holding History

Stevens First Principles Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$1.58M	Sell	31,660 -680	-2%	-$34.1K	0.92%	33
2019 Q1	$1.69M	Sell	32,340 -2,294	-7%	-$115K	1.01%	32
2018 Q4	$1.65M	Buy	34,634 +720	+2%	+$35.5K	1.12%	30
2018 Q3	$1.7M	Buy	33,914 +1,144	+3%	+$58.1K	0.98%	33
2018 Q2	$1.65M	Sell	32,770 -24	-0.1%	-$1.21K	1%	33
2018 Q1	$1.6M	Sell	32,794 -134	-0.4%	-$6.24K	0.98%	33
2017 Q4	$1.46M	Buy	32,928 +498	+2%	+$23K	0.79%	40
2017 Q3	$1.65M	Buy	32,430 +1,428	+5%	+$72.4K	0.9%	37
2017 Q2	$1.67M	Sell	31,002 -208	-0.7%	-$11.1K	0.99%	38
2017 Q1	$1.65M	Buy	31,210 +452	+1%	+$22.9K	1.05%	36
2016 Q4	$1.48M	Buy	30,758 +980	+3%	+$48.4K	1.03%	35
2016 Q3	$1.6M	Sell	29,778 -192	-0.6%	-$10.5K	1.16%	32
2016 Q2	$1.62M	Sell	29,970 -816	-3%	-$43K	1.21%	31
2016 Q1	$1.56M	Sell	30,786 -30	-0.1%	-$1.49K	1.26%	28
2015 Q4	$1.55M	Sell	30,816 -2,244	-7%	-$114K	1.32%	29
2015 Q3	$1.59M	Sell	33,060 -48	-0.1%	-$2.5K	1.27%	30
2015 Q2	$1.72M	Buy	33,108 +2,148	+7%	+$121K	1.12%	34
2015 Q1	$1.79M	Buy	30,960 +1,216	+4%	+$69.7K	1.15%	33
2014 Q4	$1.59M	Buy	29,744 +1,788	+6%	+$100K	1.05%	36
2014 Q3	$1.61M	Buy	27,956 +4,688	+20%	+$287K	0.9%	42
2014 Q2	$1.55M	Sell	23,268 -80	-0.3%	-$5.42K	0.85%	43
2014 Q1	$1.56M	Buy	23,348 +3,440	+17%	+$233K	1.01%	36
2013 Q4	$1.33M	Hold	19,908	–	–	0.79%	45
2013 Q3	$1.25M	Buy	19,908 +4,004	+25%	+$258K	0.74%	48
2013 Q2	$993K	Buy	+15,904	New	+$1.01M	0.7%	49

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Stevens First Principles Investment Advisors's GSK Position: Q2 2019 in Review

Stevens First Principles Investment Advisors reduced its GSK (GSK) stake by 2.1% in Q2 2019, selling an estimated $34.1K and leaving 31,660 shares worth $1.58M. The position accounts for 0.92% of the portfolio, ranked #33.

Stevens First Principles Investment Advisors first reported a position in GSK in Q2 2013 and has held it in 25 quarters since. The position peaked at $1.79M in Q1 2015. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

Stevens First Principles Investment Advisors held 31,660 shares of GSK worth $1.58M as of Q2 2019.
Stevens First Principles Investment Advisors sold 680 GSK shares in Q2 2019, an estimated $34.1K.
GSK made up 0.92% of Stevens First Principles Investment Advisors's portfolio in Q2 2019, its #33 holding.
Stevens First Principles Investment Advisors first reported a position in GSK in Q2 2013 and has held it in 25 quarters since.
Stevens First Principles Investment Advisors's GSK position peaked at $1.79M in Q1 2015.
804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Stevens First Principles Investment Advisors's 13F filing for Q2 2019, filed 22 Jul 2019.